Knuff & CO LLC Gilead Sciences, Inc. Transaction History

Knuff & CO LLC

$323 Million
Q3 2024

A detailed history of Knuff & CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Knuff & CO LLC holds 13,276 shares of GILD stock, worth $1.23 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

13,276

Previous 13,246 0.23%

Holding current value

$1.23 Million

Previous $908,000 22.47%

% of portfolio

0.34%

Previous 0.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $1,997 - $2,519	30 Added 0.23%	13,276 $1.11 Million
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $336,273 - $388,086	-5,325 Reduced 28.67%	13,246 $908,000
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $35,790 - $43,645	-500 Reduced 2.62%	18,571 $1.36 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $278,426 - $315,742	-3,800 Reduced 16.61%	19,071 $1.54 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $14,788 - $16,134	-200 Reduced 0.87%	22,871 $1.71 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $45,606 - $52,020	-600 Reduced 2.53%	23,071 $1.78 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $25,898 - $29,506	-335 Reduced 1.4%	23,671 $1.96 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $53,288 - $60,868	895 Added 3.87%	24,006 $1.48 Million
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $63,492 - $71,511	-1,100 Reduced 4.54%	23,111 $1.43 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $764,254 - $957,693	-13,195 Reduced 35.28%	24,211 $1.44 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $140,789 - $159,798	-2,170 Reduced 5.48%	37,406 $2.72 Million
Q3 2021 Nov 16, 2021	SELL	$67.69 - $73.03 $72,766 - $78,507	-1,075 Reduced 2.64%	39,576 $2.76 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $28,561 - $31,207	-450 Reduced 1.09%	40,651 $2.8 Million
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $184,200 - $210,172	-3,070 Reduced 6.95%	41,101 $2.66 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $49,852 - $56,804	-880 Reduced 1.95%	44,171 $2.57 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $164,254 - $206,521	2,645 Added 6.24%	45,051 $2.85 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $161,028 - $186,984	2,226 Added 5.54%	42,406 $3.26 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $332,878 - $426,369	5,315 Added 15.24%	40,180 $3 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $34,199 - $37,617	555 Added 1.62%	34,865 $2.27 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $48,132 - $53,130	770 Added 2.3%	34,310 $2.18 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $100,538 - $112,742	1,625 Added 5.09%	33,540 $2.27 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $42,520 - $47,634	680 Added 2.18%	31,915 $2.08 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.89 Million - $2.47 Million	31,235 New	31,235 $1.95 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account